This year’s Eric D. Hadar Distinguished Lecturer, Dr. Rajita Sinha, will present “Can We Rescue Stress and Trauma Related Pathophysiology in Addiction to Improve Treatment Outcomes?” on Nov. 16, 2022.
"We need better drugs and new drugs, not just the psychedelics and the ketamine, but new allotted treatments that are more effective," said Dr. David Hellerstein.
“There is a very important place for stimulant medication in the treatment of ADHD, and we have to be good guardians to know who is going to be best served by them," said Dr. Frances Levin.
“When they’re searching for something that makes the patient symptom-free, they create problems that can result in what is politely called pharmaceutical misadventure." Dr. Mark Olfson said.
In this Q & A, Dr. Lauren Hoffman discusses social anxiety disorder, how virtual reality therapy works, and why VR treatment is a promising option for teens and young adults.
“The APA doesn’t really have an official position on the best way to treat the kids,” says Jack Drescher, MD, a clinical professor of psychiatry at Columbia regarding gender-affirming care.
Adrian Jacques Ambrose, MD, MPH, FAPA, medical director of the Columbia Psychiatry Faculty Practice Organization, discusses the newest research into the neuroscience of anxiety and depression.